Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage.
Kotani H, Oshima H, Boucher JC, Yamano T, Sakaguchi H, Sato S, Fukuda K, Nishiyama A, Yamashita K, Ohtsubo K, Takeuchi S, Nishiuchi T, Oshima M, Davila ML, Yano S.
Kotani H, et al. Among authors: oshima h.
J Biomed Sci. 2024 Jul 11;31(1):68. doi: 10.1186/s12929-024-01060-3.
J Biomed Sci. 2024.
PMID: 38992694
Free PMC article.